Go Premium in Our Biggest Sale Ever

Go Ultimate 75% OFF

IPHYF Stock Latest News

Company AnnouncementsInnate Pharma Announces November 18 IPH4502 Phase 1 Data Event4h ago6K

Company AnnouncementsInnate Pharma to Host IPH4502 Phase 1 Data Event1d ago
RatingsBuy Rating Reaffirmed as IPH4502, PACIFIC-9, and Lacutamab Catalysts Support Unchanged $9 Price Target6d agoIPHA
Company AnnouncementsInnate Pharma Reports Stronger Cash Position and Pipeline Progress1w ago
The FlyInnate Pharma announces AstraZeneca updated timing for PACIFIC-9 data readout2w agoAZN IPHA

AstraZeneca Pushes Back PACIFIC-9 Lung Cancer Trial Readout, Extending Timeline for Innate Pharma’s Monalizumab

Company AnnouncementsAstraZeneca Pushes Back PACIFIC-9 Lung Cancer Trial Readout, Extending Timeline for Innate Pharma’s Monalizumab2w ago

Company AnnouncementsInnate Pharma to Highlight Cancer Immunotherapy Pipeline at November Investor Conferences3w ago

Company AnnouncementsInnate Pharma to Host Q3 2026 Business Update Call3w ago

Company AnnouncementsInnate Pharma Maps Pivotal Path in Earnings Call1M ago
Company AnnouncementsInnate Pharma Secures Sobi Partnership Cash and Extends Runway as Key Oncology Trials Advance1M ago
Company AnnouncementsInnate Pharma-Sobi Partnership Closes, Unlocks $75 Million and Phase 3 Lacutamab Trial1M ago
The FlyInnate Pharma says previously announced partnership with Sobi now effective1M agoIPHA

Innate Pharma to deliver H1 2026 business update via investor webcast

Company AnnouncementsInnate Pharma to deliver H1 2026 business update via investor webcast2M ago

Company AnnouncementsInnate Pharma to Highlight Oncology Pipeline at H.C. Wainwright Investment Conference2M ago

Company AnnouncementsInnate Pharma to Spotlight Oncology Pipeline at H.C. Wainwright Investor Conference2M ago

Company AnnouncementsInnate Pharma Raises €30 Million in Private Share Placement to Fund Oncology Pipeline2M ago6K
The FlyInnate Pharma price target raised to $9 from $8 at BTIG2M agoIPHA
Company AnnouncementsInnate Pharma Schedules Investor Call as Oncology Pipeline Advances3M ago
Company AnnouncementsInnate Pharma Raises €30 Million in Share Offering to Extend Cash Runway3M ago

Innate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway

Company AnnouncementsInnate Pharma launches €22.5m share placement to fund ADC pipeline and extend runway3M ago

The FlyLeerink upgrades Innate Pharma to Outperform after lacutamab deal3M agoIPHA

The FlyInnate Pharma upgraded to Outperform from Market Perform at Leerink3M agoIPHA